Azole Endothelin Antagonists. 3. Using Δ log P as a Tool To Improve Absorption
The oral absorption profile of a family of azole-based ETA-selective antagonists has been improved through a rational series of structural modifications which were suggested by analysis of the physicochemical parameter Δ log P. Comparison of urea 2 with a series of well-absorbed compounds using Δ lo...
Gespeichert in:
Veröffentlicht in: | Journal of medicinal chemistry 1996-02, Vol.39 (4), p.982-991 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 991 |
---|---|
container_issue | 4 |
container_start_page | 982 |
container_title | Journal of medicinal chemistry |
container_volume | 39 |
creator | von Geldern, Thomas W Hoffman, Daniel J Kester, Jeffrey A Nellans, Hugh N Dayton, Brian D Calzadilla, Samuel V Marsh, Kennan C Hernandez, Lisa Chiou, William Dixon, Douglas B Wu-Wong, Jinshyun R Opgenorth, Terry J |
description | The oral absorption profile of a family of azole-based ETA-selective antagonists has been improved through a rational series of structural modifications which were suggested by analysis of the physicochemical parameter Δ log P. Comparison of urea 2 with a series of well-absorbed compounds using Δ log P analysis suggested that 2 has an excess capacity for forming hydrogen bonds with solvent. A series of urea modifications were explored as a means of reducing H-bonding capacity while maintaining affinity for the ETA-receptor. The correlation between Δ log P values and absorption in an intraduodenal (id) bioavailability model was good; this strategy uncovered replacements for each of the urea NH groups which simultaneously improve both potency and drug absorption. A combination of these optimized modifications produces carbamate 16h, a highly-selective ETA antagonist with a potency/bioavailability profile consistent with an oral route of administration. |
doi_str_mv | 10.1021/jm9505932 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77999216</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77999216</sourcerecordid><originalsourceid>FETCH-LOGICAL-a375t-37ab37e5ffe91df46e8b48f4be48541adc70e57b89ec84d3093628a438a2aecf3</originalsourceid><addsrcrecordid>eNptkMtKw0AUhgdRaq0ufABhNgouUueWZLIMpbaFYiu2IG6GSXJSU5NMzaSiPofP5TOZktKVm3MW_8e5fAhdUtKnhNG7dRG4xA04O0Jd6jLiCEnEMeoSwpjDPMZP0Zm1a0IIp4x3UEd6nAlGu2gWfpsc8LBMTP0KeVbisKz1ypSZrW0f8z5e2qxc4d8fnJsVnmNtscYLY_Km4EmxqcwH4DCyptrUmSnP0UmqcwsX-95Dy_vhYjB2prPRZBBOHc19t3a4ryPug5umENAkFR7ISMhURCCkK6hOYp-A60cygFiKhJOAe0xqwaVmGuKU99BNO7c54H0LtlZFZmPIc12C2Vrl-0EQMOo14G0LxpWxtoJUbaqs0NWXokTt5KmDvIa92g_dRgUkB3Jvq8mdNm_kwOch1tWb8vzmL7WYP6nR4-L5gb2M1Y6_bnkdW7U226pslPyz9w-m1IPK</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77999216</pqid></control><display><type>article</type><title>Azole Endothelin Antagonists. 3. Using Δ log P as a Tool To Improve Absorption</title><source>ACS Publications</source><source>MEDLINE</source><creator>von Geldern, Thomas W ; Hoffman, Daniel J ; Kester, Jeffrey A ; Nellans, Hugh N ; Dayton, Brian D ; Calzadilla, Samuel V ; Marsh, Kennan C ; Hernandez, Lisa ; Chiou, William ; Dixon, Douglas B ; Wu-Wong, Jinshyun R ; Opgenorth, Terry J</creator><creatorcontrib>von Geldern, Thomas W ; Hoffman, Daniel J ; Kester, Jeffrey A ; Nellans, Hugh N ; Dayton, Brian D ; Calzadilla, Samuel V ; Marsh, Kennan C ; Hernandez, Lisa ; Chiou, William ; Dixon, Douglas B ; Wu-Wong, Jinshyun R ; Opgenorth, Terry J</creatorcontrib><description>The oral absorption profile of a family of azole-based ETA-selective antagonists has been improved through a rational series of structural modifications which were suggested by analysis of the physicochemical parameter Δ log P. Comparison of urea 2 with a series of well-absorbed compounds using Δ log P analysis suggested that 2 has an excess capacity for forming hydrogen bonds with solvent. A series of urea modifications were explored as a means of reducing H-bonding capacity while maintaining affinity for the ETA-receptor. The correlation between Δ log P values and absorption in an intraduodenal (id) bioavailability model was good; this strategy uncovered replacements for each of the urea NH groups which simultaneously improve both potency and drug absorption. A combination of these optimized modifications produces carbamate 16h, a highly-selective ETA antagonist with a potency/bioavailability profile consistent with an oral route of administration.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm9505932</identifier><identifier>PMID: 8632421</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Administration, Oral ; Animals ; Azepines - pharmacokinetics ; Azoles - chemical synthesis ; Azoles - chemistry ; Azoles - pharmacokinetics ; Drug Design ; Endothelin Receptor Antagonists ; Hydrogen Bonding ; Indicators and Reagents ; Indoles - pharmacokinetics ; Injections, Intravenous ; Intestinal Absorption ; Kinetics ; Male ; Metabolic Clearance Rate ; Models, Biological ; Rats ; Rats, Sprague-Dawley ; Receptor, Endothelin A ; Receptors, Endothelin - metabolism ; Structure-Activity Relationship</subject><ispartof>Journal of medicinal chemistry, 1996-02, Vol.39 (4), p.982-991</ispartof><rights>Copyright © 1996 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a375t-37ab37e5ffe91df46e8b48f4be48541adc70e57b89ec84d3093628a438a2aecf3</citedby><cites>FETCH-LOGICAL-a375t-37ab37e5ffe91df46e8b48f4be48541adc70e57b89ec84d3093628a438a2aecf3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm9505932$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm9505932$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8632421$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>von Geldern, Thomas W</creatorcontrib><creatorcontrib>Hoffman, Daniel J</creatorcontrib><creatorcontrib>Kester, Jeffrey A</creatorcontrib><creatorcontrib>Nellans, Hugh N</creatorcontrib><creatorcontrib>Dayton, Brian D</creatorcontrib><creatorcontrib>Calzadilla, Samuel V</creatorcontrib><creatorcontrib>Marsh, Kennan C</creatorcontrib><creatorcontrib>Hernandez, Lisa</creatorcontrib><creatorcontrib>Chiou, William</creatorcontrib><creatorcontrib>Dixon, Douglas B</creatorcontrib><creatorcontrib>Wu-Wong, Jinshyun R</creatorcontrib><creatorcontrib>Opgenorth, Terry J</creatorcontrib><title>Azole Endothelin Antagonists. 3. Using Δ log P as a Tool To Improve Absorption</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>The oral absorption profile of a family of azole-based ETA-selective antagonists has been improved through a rational series of structural modifications which were suggested by analysis of the physicochemical parameter Δ log P. Comparison of urea 2 with a series of well-absorbed compounds using Δ log P analysis suggested that 2 has an excess capacity for forming hydrogen bonds with solvent. A series of urea modifications were explored as a means of reducing H-bonding capacity while maintaining affinity for the ETA-receptor. The correlation between Δ log P values and absorption in an intraduodenal (id) bioavailability model was good; this strategy uncovered replacements for each of the urea NH groups which simultaneously improve both potency and drug absorption. A combination of these optimized modifications produces carbamate 16h, a highly-selective ETA antagonist with a potency/bioavailability profile consistent with an oral route of administration.</description><subject>Administration, Oral</subject><subject>Animals</subject><subject>Azepines - pharmacokinetics</subject><subject>Azoles - chemical synthesis</subject><subject>Azoles - chemistry</subject><subject>Azoles - pharmacokinetics</subject><subject>Drug Design</subject><subject>Endothelin Receptor Antagonists</subject><subject>Hydrogen Bonding</subject><subject>Indicators and Reagents</subject><subject>Indoles - pharmacokinetics</subject><subject>Injections, Intravenous</subject><subject>Intestinal Absorption</subject><subject>Kinetics</subject><subject>Male</subject><subject>Metabolic Clearance Rate</subject><subject>Models, Biological</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptor, Endothelin A</subject><subject>Receptors, Endothelin - metabolism</subject><subject>Structure-Activity Relationship</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkMtKw0AUhgdRaq0ufABhNgouUueWZLIMpbaFYiu2IG6GSXJSU5NMzaSiPofP5TOZktKVm3MW_8e5fAhdUtKnhNG7dRG4xA04O0Jd6jLiCEnEMeoSwpjDPMZP0Zm1a0IIp4x3UEd6nAlGu2gWfpsc8LBMTP0KeVbisKz1ypSZrW0f8z5e2qxc4d8fnJsVnmNtscYLY_Km4EmxqcwH4DCyptrUmSnP0UmqcwsX-95Dy_vhYjB2prPRZBBOHc19t3a4ryPug5umENAkFR7ISMhURCCkK6hOYp-A60cygFiKhJOAe0xqwaVmGuKU99BNO7c54H0LtlZFZmPIc12C2Vrl-0EQMOo14G0LxpWxtoJUbaqs0NWXokTt5KmDvIa92g_dRgUkB3Jvq8mdNm_kwOch1tWb8vzmL7WYP6nR4-L5gb2M1Y6_bnkdW7U226pslPyz9w-m1IPK</recordid><startdate>19960216</startdate><enddate>19960216</enddate><creator>von Geldern, Thomas W</creator><creator>Hoffman, Daniel J</creator><creator>Kester, Jeffrey A</creator><creator>Nellans, Hugh N</creator><creator>Dayton, Brian D</creator><creator>Calzadilla, Samuel V</creator><creator>Marsh, Kennan C</creator><creator>Hernandez, Lisa</creator><creator>Chiou, William</creator><creator>Dixon, Douglas B</creator><creator>Wu-Wong, Jinshyun R</creator><creator>Opgenorth, Terry J</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19960216</creationdate><title>Azole Endothelin Antagonists. 3. Using Δ log P as a Tool To Improve Absorption</title><author>von Geldern, Thomas W ; Hoffman, Daniel J ; Kester, Jeffrey A ; Nellans, Hugh N ; Dayton, Brian D ; Calzadilla, Samuel V ; Marsh, Kennan C ; Hernandez, Lisa ; Chiou, William ; Dixon, Douglas B ; Wu-Wong, Jinshyun R ; Opgenorth, Terry J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a375t-37ab37e5ffe91df46e8b48f4be48541adc70e57b89ec84d3093628a438a2aecf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Administration, Oral</topic><topic>Animals</topic><topic>Azepines - pharmacokinetics</topic><topic>Azoles - chemical synthesis</topic><topic>Azoles - chemistry</topic><topic>Azoles - pharmacokinetics</topic><topic>Drug Design</topic><topic>Endothelin Receptor Antagonists</topic><topic>Hydrogen Bonding</topic><topic>Indicators and Reagents</topic><topic>Indoles - pharmacokinetics</topic><topic>Injections, Intravenous</topic><topic>Intestinal Absorption</topic><topic>Kinetics</topic><topic>Male</topic><topic>Metabolic Clearance Rate</topic><topic>Models, Biological</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptor, Endothelin A</topic><topic>Receptors, Endothelin - metabolism</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>von Geldern, Thomas W</creatorcontrib><creatorcontrib>Hoffman, Daniel J</creatorcontrib><creatorcontrib>Kester, Jeffrey A</creatorcontrib><creatorcontrib>Nellans, Hugh N</creatorcontrib><creatorcontrib>Dayton, Brian D</creatorcontrib><creatorcontrib>Calzadilla, Samuel V</creatorcontrib><creatorcontrib>Marsh, Kennan C</creatorcontrib><creatorcontrib>Hernandez, Lisa</creatorcontrib><creatorcontrib>Chiou, William</creatorcontrib><creatorcontrib>Dixon, Douglas B</creatorcontrib><creatorcontrib>Wu-Wong, Jinshyun R</creatorcontrib><creatorcontrib>Opgenorth, Terry J</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>von Geldern, Thomas W</au><au>Hoffman, Daniel J</au><au>Kester, Jeffrey A</au><au>Nellans, Hugh N</au><au>Dayton, Brian D</au><au>Calzadilla, Samuel V</au><au>Marsh, Kennan C</au><au>Hernandez, Lisa</au><au>Chiou, William</au><au>Dixon, Douglas B</au><au>Wu-Wong, Jinshyun R</au><au>Opgenorth, Terry J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Azole Endothelin Antagonists. 3. Using Δ log P as a Tool To Improve Absorption</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>1996-02-16</date><risdate>1996</risdate><volume>39</volume><issue>4</issue><spage>982</spage><epage>991</epage><pages>982-991</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><abstract>The oral absorption profile of a family of azole-based ETA-selective antagonists has been improved through a rational series of structural modifications which were suggested by analysis of the physicochemical parameter Δ log P. Comparison of urea 2 with a series of well-absorbed compounds using Δ log P analysis suggested that 2 has an excess capacity for forming hydrogen bonds with solvent. A series of urea modifications were explored as a means of reducing H-bonding capacity while maintaining affinity for the ETA-receptor. The correlation between Δ log P values and absorption in an intraduodenal (id) bioavailability model was good; this strategy uncovered replacements for each of the urea NH groups which simultaneously improve both potency and drug absorption. A combination of these optimized modifications produces carbamate 16h, a highly-selective ETA antagonist with a potency/bioavailability profile consistent with an oral route of administration.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>8632421</pmid><doi>10.1021/jm9505932</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-2623 |
ispartof | Journal of medicinal chemistry, 1996-02, Vol.39 (4), p.982-991 |
issn | 0022-2623 1520-4804 |
language | eng |
recordid | cdi_proquest_miscellaneous_77999216 |
source | ACS Publications; MEDLINE |
subjects | Administration, Oral Animals Azepines - pharmacokinetics Azoles - chemical synthesis Azoles - chemistry Azoles - pharmacokinetics Drug Design Endothelin Receptor Antagonists Hydrogen Bonding Indicators and Reagents Indoles - pharmacokinetics Injections, Intravenous Intestinal Absorption Kinetics Male Metabolic Clearance Rate Models, Biological Rats Rats, Sprague-Dawley Receptor, Endothelin A Receptors, Endothelin - metabolism Structure-Activity Relationship |
title | Azole Endothelin Antagonists. 3. Using Δ log P as a Tool To Improve Absorption |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T19%3A29%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Azole%20Endothelin%20Antagonists.%203.%20Using%20%CE%94%20log%20P%20as%20a%20Tool%20To%20Improve%20Absorption&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=von%20Geldern,%20Thomas%20W&rft.date=1996-02-16&rft.volume=39&rft.issue=4&rft.spage=982&rft.epage=991&rft.pages=982-991&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/jm9505932&rft_dat=%3Cproquest_cross%3E77999216%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77999216&rft_id=info:pmid/8632421&rfr_iscdi=true |